Cargando…
Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study
PURPOSE: MRI and PET are used in neuro-oncology for the detection and characterisation of lesions for malignancy to target surgical biopsy and to plan surgical resections or stereotactic radiosurgery. The critical role of short-chain fatty acids (SCFAs) in brain tumour biology has come to the forefr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611885/ https://www.ncbi.nlm.nih.gov/pubmed/37490079 http://dx.doi.org/10.1007/s00259-023-06330-0 |
_version_ | 1785128583889420288 |
---|---|
author | Islam, Shahriar Inglese, Marianna Grech-Sollars, Matthew Aravind, Preetha Dubash, Suraiya Barwick, Tara D. O’Neill, Kevin Wang, James Saleem, Azeem O’Callaghan, James Anchini, Giulio Williams, Matthew Waldman, Adam Aboagye, Eric O. |
author_facet | Islam, Shahriar Inglese, Marianna Grech-Sollars, Matthew Aravind, Preetha Dubash, Suraiya Barwick, Tara D. O’Neill, Kevin Wang, James Saleem, Azeem O’Callaghan, James Anchini, Giulio Williams, Matthew Waldman, Adam Aboagye, Eric O. |
author_sort | Islam, Shahriar |
collection | PubMed |
description | PURPOSE: MRI and PET are used in neuro-oncology for the detection and characterisation of lesions for malignancy to target surgical biopsy and to plan surgical resections or stereotactic radiosurgery. The critical role of short-chain fatty acids (SCFAs) in brain tumour biology has come to the forefront. The non-metabolised SCFA radiotracer, [(18)F]fluoropivalate (FPIA), shows low background signal in most tissues except eliminating organs and has appropriate human dosimetry. Tumour uptake of the radiotracer is, however, unknown. We investigated the uptake characteristics of FPIA in this pilot PET/MRI study. METHODS: Ten adult glioma subjects were identified based on radiological features using standard-of-care MRI prior to any surgical intervention, with subsequent histopathological confirmation of glioma subtype and grade (lower-grade – LGG – and higher-grade – HGG – patients). FPIA was injected as an intravenous bolus injection (range 342–368 MBq), and dynamic PET and MRI data were acquired simultaneously over 66 min. RESULTS: All patients tolerated the PET/MRI protocol. Three patients were reclassified following resection and histology. Tumour maximum standardised uptake value (SUV(max,60)) increased in the order LGG (WHO grade 2) < HGG (WHO grade 3) < HGG (WHO grade 4). The net irreversible solute transfer, Ki, and influx rate constant, K1, were significantly higher in HGG (p < 0.05). Of the MRI variables studied, DCE-MRI-derived extravascular-and-extracellular volume fraction (v(e)) was high in tumours of WHO grade 4 compared with other grades (p < 0.05). SLC25A20 protein expression was higher in HGG compared with LGG. CONCLUSION: Tumoural FPIA PET uptake is higher in HGG compared to LGG. This study supports further investigation of FPIA PET/MRI for brain tumour imaging in a larger patient population. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT04097535. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06330-0. |
format | Online Article Text |
id | pubmed-10611885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-106118852023-10-29 Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study Islam, Shahriar Inglese, Marianna Grech-Sollars, Matthew Aravind, Preetha Dubash, Suraiya Barwick, Tara D. O’Neill, Kevin Wang, James Saleem, Azeem O’Callaghan, James Anchini, Giulio Williams, Matthew Waldman, Adam Aboagye, Eric O. Eur J Nucl Med Mol Imaging Original Article PURPOSE: MRI and PET are used in neuro-oncology for the detection and characterisation of lesions for malignancy to target surgical biopsy and to plan surgical resections or stereotactic radiosurgery. The critical role of short-chain fatty acids (SCFAs) in brain tumour biology has come to the forefront. The non-metabolised SCFA radiotracer, [(18)F]fluoropivalate (FPIA), shows low background signal in most tissues except eliminating organs and has appropriate human dosimetry. Tumour uptake of the radiotracer is, however, unknown. We investigated the uptake characteristics of FPIA in this pilot PET/MRI study. METHODS: Ten adult glioma subjects were identified based on radiological features using standard-of-care MRI prior to any surgical intervention, with subsequent histopathological confirmation of glioma subtype and grade (lower-grade – LGG – and higher-grade – HGG – patients). FPIA was injected as an intravenous bolus injection (range 342–368 MBq), and dynamic PET and MRI data were acquired simultaneously over 66 min. RESULTS: All patients tolerated the PET/MRI protocol. Three patients were reclassified following resection and histology. Tumour maximum standardised uptake value (SUV(max,60)) increased in the order LGG (WHO grade 2) < HGG (WHO grade 3) < HGG (WHO grade 4). The net irreversible solute transfer, Ki, and influx rate constant, K1, were significantly higher in HGG (p < 0.05). Of the MRI variables studied, DCE-MRI-derived extravascular-and-extracellular volume fraction (v(e)) was high in tumours of WHO grade 4 compared with other grades (p < 0.05). SLC25A20 protein expression was higher in HGG compared with LGG. CONCLUSION: Tumoural FPIA PET uptake is higher in HGG compared to LGG. This study supports further investigation of FPIA PET/MRI for brain tumour imaging in a larger patient population. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov, NCT04097535. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06330-0. Springer Berlin Heidelberg 2023-07-25 2023 /pmc/articles/PMC10611885/ /pubmed/37490079 http://dx.doi.org/10.1007/s00259-023-06330-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Islam, Shahriar Inglese, Marianna Grech-Sollars, Matthew Aravind, Preetha Dubash, Suraiya Barwick, Tara D. O’Neill, Kevin Wang, James Saleem, Azeem O’Callaghan, James Anchini, Giulio Williams, Matthew Waldman, Adam Aboagye, Eric O. Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study |
title | Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study |
title_full | Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study |
title_fullStr | Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study |
title_full_unstemmed | Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study |
title_short | Feasibility of [(18)F]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study |
title_sort | feasibility of [(18)f]fluoropivalate hybrid pet/mri for imaging lower and higher grade glioma: a prospective first-in-patient pilot study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611885/ https://www.ncbi.nlm.nih.gov/pubmed/37490079 http://dx.doi.org/10.1007/s00259-023-06330-0 |
work_keys_str_mv | AT islamshahriar feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT inglesemarianna feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT grechsollarsmatthew feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT aravindpreetha feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT dubashsuraiya feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT barwicktarad feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT oneillkevin feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT wangjames feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT saleemazeem feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT ocallaghanjames feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT anchinigiulio feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT williamsmatthew feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT waldmanadam feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy AT aboagyeerico feasibilityof18ffluoropivalatehybridpetmriforimaginglowerandhighergradegliomaaprospectivefirstinpatientpilotstudy |